CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
11 research outputs found
Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients
Author
A Crockford
A Errico
+57Â more
A Pedoeem
Adam Jendrisak
AP Fay
Archana Anantharaman
C Robert
CE Meacham
CG Drake
CN Sternberg
David Lu
EB Garon
EJ Lipson
G Griffiths
G Kallergi
G Wickman
Gayatri Premasekharan
GK Philips
H Borghaei
H von der Maase
J Bellmunt
J Brahmer
J Zhang
JD Wolchok
JE Rosenberg
Jeffrey Hough
Jessica Louw
JH Cho-Vega
JL Perez-Gracia
K Sasaki
Karla Lindquist
Lyndsey Dugan
M Gerlinger
M Ploeg
M Razzak
M Schvimer
Matthew Edwards
P Momtaz
P Wu
Pamela L. Paris
PC Tumeh
PL Bedard
R Siegel
Rachel Krupa
RJ Motzer
Rosa Paz
RP Werner SG
RS Herbst
Ryan Dittamore
Ryon Graf
Sarah Baird
SL Topalian
SP Patel
ST Haile
T Furuya
T Okazaki
T Powles
Terence Friedlander
Yipeng Wang
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
Full text link
Crossref
Soluble programmed death-ligand 1 as a prognostic biomarker for overall survival in patients with diffuse large B-cell lymphoma: a replication study and combined analysis of 508 patients
Author
A Pedoeem
D Kwon
+13Â more
D Rossille
DS Chen
DW Scott
I Azzaoui
J Kiyasu
JW Friedberg
M Ziepert
MJ Proctor
MT Drake
N Wada
P Armand
RA Wilcox
S Riihijarvi
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
IL-10/IFNÎł co-expressing CD4+ T cells induced by IL-10 DC display a regulatory gene profile and downmodulate T cell responses
Author
Anderson
Anderson
+63Â more
Anja ten Brinke
Boks
Boks
Boks
Cardone
Corthay
Dalton
Daniel
Dominguez-Villar
Duhen
Feng
Feuerer
Fujio
Gagliani
Gerosa
Goldstein
Greenwald
Gregori
Haringer
Harry
Hsu
Hsu
Huang
Jankovic
Jonuleit
Judith R. Kager-Groenland
Keir
Kemper
Koch
Kubach
Liang
Martine A. Boks
Meyers
Nadkarni
Nakayamada
Naranjo-Gomez
Okamura
Pedoeem
Pohl-Koppe
Probst-Kepper
Roncarolo
Roncarolo
Roncarolo
S. Marieke van Ham
Saraiva
Sawitzki
Schinnerling
Shevach
Steinman
Stockis
Tarrant
Thomson
Trinchieri
Unger
Venigalla
Verma
Vignali
Wang
Wong
Yamazaki
Yanagawa
Zheng
Zhu
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
Clinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic Melanoma
Author
Abate-Daga
Ahmadzadeh
+70Â more
Andreas Reik
Atkins
Barber
Brahmer
Cai
Dale Ando
Daniel Abate-Daga
David Paschon
Dmitry Guschin
Dong
Dong
Doyon
Dudley
Edward J Rebar
Freeman
Gary Lee
Gros
Grupp
Guschin
Hamid
Hirano
Huang
Iwai
Iwama
Jeff Miller
Joal D Beane
Joung
Kochenderfer
Lipson
Maier
Mali
Martin Giedlin
Mary Black
Matthew Mendel
Michael C Holmes
Miller
Mini Bharathan
Morgan
Needleman
Nicholas P Restifo
Nimisha Gandhi
Pardoll
Pedoeem
Perez
Philip D Gregory
Pule
Radziewicz
Restifo
Richard A Morgan
Robbins
Robbins
Rosenberg
Rosenberg
Rosenberg
Smita Chandran
Steven A Feldman
Steven A Rosenberg
Tebas
Topalian
Topalian
Topalian
Tran
Tsai
Urnov
Urnov
Velu
Wu
Yamazaki
Zhili Zheng
Zhiya Yu
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Checkpoint inhibitors in immunotherapy of ovarian cancer
Author
A Bailey
A Pedoeem
+52Â more
A Ribas
AM Intlekofer
BA Goff
BW Tse
C Kyi
C Robert
C Robert
CU Blank
DE Dolan
DM Pardoll
Dong-hui Wang
E Sharon
F Ito
FS Hodi
FS Hodi
FS Hodi
H Wei
H Yano
J Hamanishi
J Krempski
J Naidoo
JM Reuben
JR Brahmer
JR Brahmer
JR Westin
JS Weber
K Abiko
K Fujita
L Lu
Liang Guo
M Bilusic
M Millward
M Muccioli
M Sznol
M Tania
MJ Butte
MJ Selby
MK Callahan
MZ Hao
O Hamid
OS Qureshi
PH Lizotte
R Berger
RJ Morgan Jr
S Mocellin
SL Topalian
SR Manjunath
VM Vargas-Hernández
Xiao-hua Wu
YC Kong
YF Yang
Z Guo
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Clinical Significance of PD-L1 Expression in Both Cancer and Stroma Cells of Cholangiocarcinoma Patients
Author
A Nakeeb
A Pedoeem
+53Â more
AH Sharpe
Akira Chikamoto
BZ Qian
C Steidl
D Walter
DM Kuang
DM Pardoll
F Gani
F Sabbatino
H Dong
H Nakamura
H Okabe
Hideo Baba
Hirohisa Okabe
J Fontugne
J West
JR Brahmer
K Ma
Katsunori Imai
L Chen
M Ahmadzadeh
M Miyazaki
M Nagino
Masayo Tsukamoto
N Hiraoka
Naoki Umezaki
O Hamid
RM Gibbons Johnson
Rumi Itoyama
S Lyford-Pike
SB Edge
Shigeki Nakagawa
SL Topalian
SM Ansell
T Patel
T Powles
T Yagi
Takanobu Yamao
Takatoshi Ishiko
Tatsunori Miyata
Toshihiko Yusa
TT Wang
VA Boussiotis
Y Bordon
Y Kitano
Y Komohara
Y Takahashi
Y Zhang
Yo-ichi Yamashita
Yosuke Nakao
Yuki Kitano
YW Li
ZG Fridlender
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Optimization and validation of PD-L1 immunohistochemistry staining protocols using the antibody clone 28-8 on different staining platforms
Author
A Marchetti
A Pedoeem
+59Â more
A Ribas
AH Scheel
AH Scheel
B Skov
Bharat Jasani
Christina Koppel
Corrado D’Arrigo
CY Mu
Dirk Zielinski
DL Barber
DL Rimm
DP Carbone
DS Chen
DS Chen
FR Hirsch
Francois Ng Kee Kwong
G Dix Junqueira Pinto
H Borghaei
H Brunnstrom
H Dong
Hans-Ulrich Schildhaus
Helena Schwellenbach
HF Essen van
I Cree
J Adam
J Brahmer
J Cogswell
J Konishi
J Novotny
J Smith
J Sun
JA Rehman
JM Taube
Josef RĂĽschoff
K Gowrishankar
K Schats
KM Mahoney
L Dyck
M Ilie
M Ilie
M Reck
M Sznol
Mercedes Martin-Ortega
P Gaule
R Buttner
R Los Santos De
S Alvarez
S Ostrand-Rosenberg
SI Pai
Sina Eckstein
SJ Lee
SP Patel
SV Hato
T Neuman
T Phillips
T Phillips
TJ Gniadek
U Janzic
YB Chen
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?
Author
A Habicht
A Pedoeem
+71Â more
A Ribas
A Snyder
AM Eggermont
BT Fife
C Robert
C Robert
C Robert
Christine E. Horak
CY Mu
D Schadendorf
DF McDermott
DF McDermott
DT Le
EB Garon
EW Alley
F Hirano
FM Burnet
FS Hodi
FS Hodi
Gerardo Botti
Giuseppe V. Masucci
GJ Freeman
GP Dunn
H Borghaei
H Dong
Ignacio Melero
J Brahmer
J Gadiot
J Larkin
Jason D. Hipp
JB Sawnn
JD Wolchok
JE Rosenberg
JM Taube
JR Brahmer
JS Weber
L Apetoh
L Fehrenbacher
LM Francisco
Lucia Festino
M Sznol
ME Keir
MJ Selby
MM Gubin
MY Mapara
MZ Noman
NA Rizvi
O Hamid
O Hamid
P Armand
Paolo A. Ascierto
Paul Lorigan
PC Tumeh
PS Linsley
PT Sage
PW Kantoff
R Nanda
RA Maldonado
RH Thompson
RJ Motzer
RS Herbst
RS Herbst
S Spranger
SL Topalian
SL Topalian
SM Ansell
T Powles
TF Gajewski
TR Simpson
W Zou
Y Iwai
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy
Author
A Pedoeem
A Pinzon-Charry
+79Â more
Aaron D. Bossler
AC Anderson
AC Anderson
Andrea R. Hallier
AT Parsa
B Reva
BN Kholodenko
C Menetrier-Caux
C Nobile
CU Blank
D Holt
D Sagar
Deepak Parashar
DH Munn
DI Gabrilovich
E Hairer
EA Lanzel
ER Sauter
F Avogadri
F Balkwill
F Bhaijee
F Skoulidis
Fang Qian
FR Hirsch
GA Rabinovich
H Borghaei
H Brunnstrom
H Dong
H Ishii
H Li
H Yu
I Perrot
IA Adzhubei
IJ Malm
IK Demedts
J Chen
J He
J McLaughlin
J Peguet-Navarro
J Sunshine
JF Grosso
K Shih
Kim A. Brogden
KJ Lastwika
KM Kerr
L Carbognin
L Monney
L Pilotte
L Zitvogel
LA Johnson
LG Martelotto
M Charmoy
Mohammed M. Milhem
N Inoshima
N Mukaida
NA Rizvi
Naiyer A. Rizvi
NM Moutsopoulos
P Kaushik
P Ritprajak
RS Herbst
S Beaulieu
S Hegde
S Lob
S Mocellin
S Spranger
SC Casey
Shireen Vali
SY Tseng
T Shukuya
Taher Abbasi
Terry Braun
Timothy A. Chan
TZ Iversen
V Chabot
Y Choi
Y Jiang
YK Chae
ZY Dong
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
The PD-1/PD-L1 pathway: biological background and clinical relevance of an emerging treatment target in immunotherapy
Author
Ahmadzadeh M
Alexandar Tzankov
+58Â more
Armand P
Azuma T
Blank C
Brahmer JR
Brahmer JR
Brahmer JR
Chapon M
Curran MA
Dai S
Day CL
Dong H
Dong H
D’Souza M
Flies DB
Gadiot J
Ghebeh H
Gianchecchi E
Gros A
Hamanishi J
Herbst RS GM
Hirano F
Hodi FS
Intlekofer AM
Ishida Y
Ishiwata K
Iwai Y
Jin HT
Keir ME
Kitazawa Y
Latchman Y
McDermott DF
Moehler MH KY
Muenst S
Pedoeem A
Powles T
Ramsay AG
Robert C
Routh JC
Savas D Soysal
Scott JA BJ
Seiwert TY
Shi L
Simone Muenst
Strome SE
Sylvia Hoeller
The Cancer Genome Atlas Research N Analysis Working Group: Dana-Farber Cancer I, Institute for Systems B, University of Southern C, Memorial Sloan Kettering Cancer C, Agency BCC
Topalian SL
Trautmann L
Tykodi SS
Velcheti V
Velu V
Wang W
Watanabe N
Wintterle S
Wolchok JD
Wu C
Yang W
Zhang X
Publication venue
'Informa Healthcare'
Publication date
Field of study
No full text
Crossref
1
2